Glatiramer Acetate
- Generic Name
- Glatiramer Acetate
- Indication
用于治疗复发型多发性硬化症（MS/罕见病），包括成人临床孤立综合征、复发-缓解性疾病和活动性继发进行性疾病。
Phase IV Study, Betaseron Versus Copaxone for Relapsing Remitting or CIS Forms of MS Using Triple Dose Gad 3 T MRI
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2021-11-16
- Target Recruit Count
- 75
- Registration Number
- NCT00176592
- Locations
- 🇺🇸
New Jersey Medical School, Newark, New Jersey, United States
BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients
Phase 3
Completed
- Conditions
- Multiple Sclerosis, Relapsing-Remitting
- Interventions
- First Posted Date
- 2004-12-16
- Last Posted Date
- 2008-12-19
- Lead Sponsor
- Bayer
- Target Recruit Count
- 2244
- Registration Number
- NCT00099502
Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis
Phase 4
Completed
- Conditions
- Relapsing-remitting Multiple Sclerosis
- Interventions
- First Posted Date
- 2004-02-26
- Last Posted Date
- 2018-06-27
- Lead Sponsor
- EMD Serono
- Target Recruit Count
- 764
- Registration Number
- NCT00078338
- Locations
- 🇷🇺
Dept of Neurology St Petersburg State Medical University, St Petersburg, Russian Federation
🇺🇸University Of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸Minor & James Medical, PLLC, Seattle, Washington, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath